GSK Unveils New Corporate Brand Identity

GSK Announces New Corporate Brand Identity Following the separation of its pharmaceutical and consumer health divisions, GSK has announced a new corporate brand identity, marking the company's most significant transformation in 20 years. The company will continue its operations with the new visual identity starting from June of this year. One of the world's leading pharmaceutical companies, GSK, had announced in mid-2022 that it would separate its pharmaceutical and consumer health divisions to focus on pharmaceuticals in the healthcare sector. In line with this, GSK has renewed its visual identity and will continue its operations with the new logo. GSK is moving forward with its new brand identity that reflects its new vision, combining science, technology and talent in disease prevention, with the tagline "Together Ahead". The logo redesign reflects the company's new vision focused on 100% biopharmaceutical innovation, preserving the orange colour associated with the brand while alluding to the company's pioneering stance in technology and digitalisation. GSK will focus on four main therapeutic areas: infectious diseases, HIV, oncology and immunology. In February of last year, the company announced that its consumer health division would separate from GSK to operate as an independent company called Haleon.